After stage 4 colorectal cancer spread to his liver, a multidisciplinary team at NewYork-Presbyterian/Columbia recommended chemotherapy and a living donor liver transplant, offering Thomas Calvo a second chance.
Researchers found that a rare inherited EGFR mutation may raise lung cancer risk up to 25-fold. An oncologist explains what the findings could mean for patients.